196 related articles for article (PubMed ID: 11902731)
1. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
2. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
3. Leukemia in Down syndrome: a review.
Zipursky A; Poon A; Doyle J
Pediatr Hematol Oncol; 1992; 9(2):139-49. PubMed ID: 1388043
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
[TBL] [Abstract][Full Text] [Related]
5. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
[TBL] [Abstract][Full Text] [Related]
6. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
Hitzler JK; Cheung J; Li Y; Scherer SW; Zipursky A
Blood; 2003 Jun; 101(11):4301-4. PubMed ID: 12586620
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
Massey GV; Zipursky A; Chang MN; Doyle JJ; Nasim S; Taub JW; Ravindranath Y; Dahl G; Weinstein HJ;
Blood; 2006 Jun; 107(12):4606-13. PubMed ID: 16469874
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
Zipursky A; Christensen H; De Harven E
Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
[TBL] [Abstract][Full Text] [Related]
10. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
11. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
12. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
[TBL] [Abstract][Full Text] [Related]
13. Target cell of leukemic transformation in acute megakaryoblastic leukemia.
Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T
Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321
[TBL] [Abstract][Full Text] [Related]
14. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
[TBL] [Abstract][Full Text] [Related]
15. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
[TBL] [Abstract][Full Text] [Related]
16. Transient leukemia in newborns with Down syndrome.
Massey GV
Pediatr Blood Cancer; 2005 Jan; 44(1):29-32. PubMed ID: 15558701
[TBL] [Abstract][Full Text] [Related]
17. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
[TBL] [Abstract][Full Text] [Related]
18. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Klusmann JH; Li Z; Böhmer K; Maroz A; Koch ML; Emmrich S; Godinho FJ; Orkin SH; Reinhardt D
Genes Dev; 2010 Mar; 24(5):478-90. PubMed ID: 20194440
[TBL] [Abstract][Full Text] [Related]
19. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome.
Nikolaev SI; Santoni F; Vannier A; Falconnet E; Giarin E; Basso G; Hoischen A; Veltman JA; Groet J; Nizetic D; Antonarakis SE
Blood; 2013 Jul; 122(4):554-61. PubMed ID: 23733339
[TBL] [Abstract][Full Text] [Related]
20. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]